Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentavalent meningococcal ABCYW vaccine in adults and adolescents
NCT06128733Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2023
- Primary completion
- Aug 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of Meningococcal ABCYW vaccine in meningococcal disease, sponsored by Sanofi. Started Oct 2023; status: completed.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT06128733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06128733.